Previous close | 24.86 |
Open | 25.00 |
Bid | 24.45 x 300 |
Ask | 24.54 x 300 |
Day's range | 24.25 - 25.42 |
52-week range | 19.37 - 47.48 |
Volume | |
Avg. volume | 1,501,517 |
Market cap | 2.398B |
Beta (5Y monthly) | 1.85 |
PE ratio (TTM) | N/A |
EPS (TTM) | -5.42 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 70.61 |
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript May 9, 2024 Intellia Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to Intellia Therapeutics’ First Quarter 2024 Financial Results Conference Call. My name is […]
Comprehensive Analysis of Financial Performance and Operational Highlights
Intellia's (NTLA) earnings and revenues surpass estimates in the first quarter of 2024. The company provides developmental and regulatory updates on its pipeline candidates. Stock rises.